Selinexor in Combination With Immunomodulator (Thalidomide/Pomalidomide/Lenalidomide)in RRMM
Condition(s):Multiple MyelomaLast Updated:February 27, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:February 27, 2023Recruiting
Condition(s):Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Mantle Cell Lymphoma; B-cell Prolymphocytic Leukemia; Diffuse Large Cell LymphomaLast Updated:December 6, 2016Unknown status
Condition(s):Non-Hodgkin’s LymphomaLast Updated:September 30, 2009Unknown status
Condition(s):LymphomaLast Updated:December 27, 2023Completed
Condition(s):LymphomaLast Updated:September 7, 2023Completed
Condition(s):LymphomaLast Updated:December 19, 2013Unknown status
Condition(s):Childhood Acute Lymphoblastic LeukemiaLast Updated:January 25, 2021Recruiting
Condition(s):LymphomaLast Updated:December 19, 2013Unknown status
Condition(s):Cancer of RectumLast Updated:August 14, 2023Recruiting
Condition(s):Lymphoma; Lymphoma, Large B-Cell, DiffuseLast Updated:February 23, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.